Review



tnf α elisa kits  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Elabscience Biotechnology tnf α elisa kits
    In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 <t>and</t> <t>TNF-α</t> surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Tnf α Elisa Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 454 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/pmc12859459-283-32-35?v=Elabscience+Biotechnology
    Average 96 stars, based on 454 article reviews
    tnf α elisa kits - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "Precisely regulated physically-crosslinked carriers enable synergetic release of bioactive factors for MSC-mediated cartilage regeneration"

    Article Title: Precisely regulated physically-crosslinked carriers enable synergetic release of bioactive factors for MSC-mediated cartilage regeneration

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.01.009

    In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 and TNF-α surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Figure Legend Snippet: In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 and TNF-α surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.

    Techniques Used: In Vivo, Staining



    Similar Products

    94
    Guangzhou JET Bio-Filtration rat tnf-α (tumor necrosis factor alpha) elisa kit
    Rat Tnf α (Tumor Necrosis Factor Alpha) Elisa Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/custom-e-el-r2856-42281949?v=Guangzhou+JET+Bio-Filtration
    Average 94 stars, based on 1 article reviews
    rat tnf-α (tumor necrosis factor alpha) elisa kit - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology tnf α elisa kits
    In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 <t>and</t> <t>TNF-α</t> surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    Tnf α Elisa Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/pmc12859459-283-32-35?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    tnf α elisa kits - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology e el r2856
    In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 <t>and</t> <t>TNF-α</t> surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.
    E El R2856, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/pmc13015246-19-8-5?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    e el r2856 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology rat tnf α elisa kit
    Prostaglandin dysregulation and inflammatory response in the RPP model (A–C) Uterine PGF 2α (A), PGE 2 (B), and PGF 2α /PGE 2 ratio (C) on days 12 and 24 of RPP modeling ( n = 3). (D) The protein levels of COX-2 in the uterine tissue on days 12 and 24 of RPP modeling ( n = 3). (E–G) The levels of IL-1β (E), IL-6 (F), <t>and</t> <t>TNF-α</t> (G) in the serum on days 12 and 24 of RPP modeling ( n = 3). Data are presented as the mean ± SD; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, one-way ANOVA.
    Rat Tnf α Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/pmc13015246-19-0-5?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    rat tnf α elisa kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology myocardial homogenate
    Prostaglandin dysregulation and inflammatory response in the RPP model (A–C) Uterine PGF 2α (A), PGE 2 (B), and PGF 2α /PGE 2 ratio (C) on days 12 and 24 of RPP modeling ( n = 3). (D) The protein levels of COX-2 in the uterine tissue on days 12 and 24 of RPP modeling ( n = 3). (E–G) The levels of IL-1β (E), IL-6 (F), <t>and</t> <t>TNF-α</t> (G) in the serum on days 12 and 24 of RPP modeling ( n = 3). Data are presented as the mean ± SD; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, one-way ANOVA.
    Myocardial Homogenate, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/pm41965382-78-20-16?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    myocardial homogenate - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology tumor necrosis factor alpha
    Prostaglandin dysregulation and inflammatory response in the RPP model (A–C) Uterine PGF 2α (A), PGE 2 (B), and PGF 2α /PGE 2 ratio (C) on days 12 and 24 of RPP modeling ( n = 3). (D) The protein levels of COX-2 in the uterine tissue on days 12 and 24 of RPP modeling ( n = 3). (E–G) The levels of IL-1β (E), IL-6 (F), <t>and</t> <t>TNF-α</t> (G) in the serum on days 12 and 24 of RPP modeling ( n = 3). Data are presented as the mean ± SD; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, one-way ANOVA.
    Tumor Necrosis Factor Alpha, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/pm41965382-78-11-16?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    tumor necrosis factor alpha - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Elabscience Biotechnology elisa commercial kits
    Prostaglandin dysregulation and inflammatory response in the RPP model (A–C) Uterine PGF 2α (A), PGE 2 (B), and PGF 2α /PGE 2 ratio (C) on days 12 and 24 of RPP modeling ( n = 3). (D) The protein levels of COX-2 in the uterine tissue on days 12 and 24 of RPP modeling ( n = 3). (E–G) The levels of IL-1β (E), IL-6 (F), <t>and</t> <t>TNF-α</t> (G) in the serum on days 12 and 24 of RPP modeling ( n = 3). Data are presented as the mean ± SD; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, one-way ANOVA.
    Elisa Commercial Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+el+r2856/10__1080_slash_0886022x__2026__2652103-51-16-25?v=Elabscience+Biotechnology
    Average 96 stars, based on 1 article reviews
    elisa commercial kits - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 and TNF-α surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.

    Journal: Bioactive Materials

    Article Title: Precisely regulated physically-crosslinked carriers enable synergetic release of bioactive factors for MSC-mediated cartilage regeneration

    doi: 10.1016/j.bioactmat.2026.01.009

    Figure Lengend Snippet: In vivo chondrogenesis of hydrogels incorporated with different combinations of PSF and KSF. (a) Alcian blue and Safranin O staining of different combinations after 21-day implantation. G1: 5 % β-sheet PSF +5 % β-sheet KSF; G2: 15 % β-sheet PSF +30 % β-sheet KSF; G3: 30 % β-sheet PSF +40 % β-sheet KSF; G4: 40 % β-sheet PSF +50 % β-sheet KSF. Scale bar = 200 μm. (b–d) Quantitative analysis of IL-1β, IL-6 and TNF-α surrounding defect cartilage 1 week and 3 weeks after operation. (e, f) Macroscopic and MRI observations of rat femoral condyles at week 6 and 12. Red circles and red arrows show the original defect zone under macroscope and MRI respectively. Scale bar = 1 mm. (g) Relative ratio of average optical density (versus G1) that shows the staining intensity of Alcian blue and Safranin O staining. (h) ICRS scoring of macroscopic evaluations. (i) The repaired cartilage using a nanoindentation instrument. Scale bar = 1 cm. (j, k) Reduced modulus and hardness of the regenerated cartilage. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001.

    Article Snippet: The suspension was centrifuged at 10,000 rpm for 10 min at 4 °C, and the supernatant was collected, and Elisa assay was performed following the manufacturer's instructions for rat IL-1β, IL-6, and TNF-α ELISA kits (Elabscience, China).

    Techniques: In Vivo, Staining

    Prostaglandin dysregulation and inflammatory response in the RPP model (A–C) Uterine PGF 2α (A), PGE 2 (B), and PGF 2α /PGE 2 ratio (C) on days 12 and 24 of RPP modeling ( n = 3). (D) The protein levels of COX-2 in the uterine tissue on days 12 and 24 of RPP modeling ( n = 3). (E–G) The levels of IL-1β (E), IL-6 (F), and TNF-α (G) in the serum on days 12 and 24 of RPP modeling ( n = 3). Data are presented as the mean ± SD; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, one-way ANOVA.

    Journal: iScience

    Article Title: A pharmacological rat model of recurrent pelvic pain exhibiting hyperalgesia and depression-like behaviors

    doi: 10.1016/j.isci.2026.115059

    Figure Lengend Snippet: Prostaglandin dysregulation and inflammatory response in the RPP model (A–C) Uterine PGF 2α (A), PGE 2 (B), and PGF 2α /PGE 2 ratio (C) on days 12 and 24 of RPP modeling ( n = 3). (D) The protein levels of COX-2 in the uterine tissue on days 12 and 24 of RPP modeling ( n = 3). (E–G) The levels of IL-1β (E), IL-6 (F), and TNF-α (G) in the serum on days 12 and 24 of RPP modeling ( n = 3). Data are presented as the mean ± SD; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, one-way ANOVA.

    Article Snippet: Rat TNF-α ELISA Kit , Elabscience , Cat# E-EL-R2856.

    Techniques: